A stilbenol that is stilbene in which the phenyl groups are substituted at positions 3, 5, and 4' by hydroxy groups.
Chemical ID:
MESH:C059514
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of AKT1 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of AKT1 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol results in increased phosphorylation of AKT1 protein]; [Resveratrol co-treated with Pravastatin] results in increased phosphorylation of AKT1 protein; [Resveratrol co-treated with Streptozocin] results in decreased phosphorylation of AKT1 protein; Resveratrol inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Sirolimus results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Streptozocin results in decreased expression of AKT1 mRNA]; Resveratrol results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Resveratrol results in increased phosphorylation of and results in increased activity of AKT1 protein; Wortmannin inhibits the reaction [Resveratrol results in increased phosphorylation of AKT1 protein]
resveratrol results in decreased expression of AKT1 mRNA; resveratrol results in decreased expression of AKT1 protein; resveratrol results in decreased expression of AKT1 protein modified form
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of AKT1 protein]; [Resveratrol binds to NQO2 protein] inhibits the reaction [NQO2 protein binds to AKT1 protein]; CBX7 protein inhibits the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; MIR21 mRNA inhibits the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; MRK 003 affects the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; NQO2 protein inhibits the reaction [Resveratrol results in decreased expression of AKT1 protein]; PTEN protein affects the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [AKT1 protein binds to NQO2 protein]; Resveratrol inhibits the reaction [AKT1 protein results in increased phosphorylation of FOXO1 protein]; Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; Resveratrol inhibits the reaction [PIK3CA protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Pyruvaldehyde results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Sirolimus results in increased phosphorylation of AKT1 protein]; Resveratrol results in decreased phosphorylation of and results in decreased activity of AKT1 protein
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]]; [Resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in increased activity of AKT1 protein; [Sirolimus co-treated with Resveratrol] promotes the reaction [TSC2 gene mutant form results in decreased phosphorylation of AKT1 protein]; PRKAA2 protein affects the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; PTPN11 protein affects the reaction [Resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of AKT1 protein]]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with TLR4] results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of AKT1 mRNA]; Resveratrol inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein]; Resveratrol promotes the reaction [TSC2 gene mutant form results in decreased phosphorylation of AKT1 protein]; Resveratrol promotes the reaction [Wortmannin results in decreased phosphorylation of AKT1 protein]; Sirolimus inhibits the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; SIRT1 protein affects the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]]; Wortmannin promotes the reaction [Resveratrol results in decreased phosphorylation of AKT1 protein]
